About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Medical Oncology
›
top-articles
Department of Medical Oncology
39
(top 2%)
papers
2.9K
(top 1%)
citations
23
(top 1%)
h
-index
38
(top 1%)
g
-index
39
all documents
3.1K
doc citations
862
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging
Journal of Clinical Oncology
2003
328
2
Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy
Nature Clinical Practice Oncology
2008
326
3
Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis
NMR in Biomedicine
2002
323
4
Phase I Clinical Trial of Weekly Combretastatin A4 Phosphate: Clinical and Pharmacokinetic Results
Journal of Clinical Oncology
2003
306
5
True
British Journal of Cancer
2000
221
6
Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels
Journal of Clinical Oncology
2001
181
7
Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial
European Radiology
2009
151
8
Surveillance policy for stage I ovarian germ cell tumors.
Journal of Clinical Oncology
1997
132
9
Cardiac complications of radiation therapy
Clinical Oncology
2005
118
10
A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites
International Journal of Gynecological Cancer
2008
115
11
The Outcome of Patients Treated with Sunitinib Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
European Urology
2011
104
12
5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study
British Journal of Cancer
2003
103
13
The gut microbiome: what the oncologist ought to know
British Journal of Cancer
2021
74
14
Testicular implants and patient satisfaction: a questionnaire-based study of men after orchidectomy for testicular cancer
BJU International
2001
69
15
Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications
European Journal of Cancer
2020
52
16
Dynamic MRI for imaging tumor microvasculature: Comparison of susceptibility and relaxivity techniques in pelvic tumors
Journal of Magnetic Resonance Imaging
2007
48
17
Sunitinib and other targeted therapies for renal cell carcinoma
British Journal of Cancer
2011
47
18
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours
British Journal of Cancer
2004
36
19
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer
Annals of Oncology
2001
34
20
Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRI
British Journal of Cancer
2005
30
21
Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome
British Journal of Cancer
2004
29
22
Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer
British Journal of Cancer
1996
28
23
Parental care and sexual size dimorphism in wasps and bees
Behavioral Ecology and Sociobiology
2008
25
24
Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy
European Journal of Cancer
1999
23
25
Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study
British Journal of Cancer
2008
22
26
Excision of residual masses of metastatic germ cell tumours after chemotherapy: the role of extraperitoneal surgical approaches
British Journal of Urology
1998
19
27
Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours
British Journal of Cancer
2000
18
28
The Clinical Value of Tumour Markers in the Management of Ovarian Cancer
Annals of Clinical Biochemistry
1996
15
29
How long should first-line chemotherapy continue?
Annals of Oncology
1999
15
30
The optimal timing for the interval to surgery after short course preoperative radiotherapy (5 ×5 Gy) in rectal cancer - are we too eager for surgery?
Cancer Treatment Reviews
2020
14
31
Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population
International Journal of Gynecological Cancer
2004
11
32
Neoadjuvant Chemotherapy without Radiation in Colorectal Cancer
Clinics in Colon and Rectal Surgery
2020
10
33
How long should first-line chemotherapy continue?
Annals of Oncology
1999
6
34
Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer
JAMA Network Open
2023
6
35
Diagnostic delay and risk of relapse in patients with stage I nonseminomatous germ cell tumour followed on active surveillance
BJU International
2000
5
36
Sex-biased parental care and sexual size dimorphism in a provisioning arthropod
Behavioral Ecology and Sociobiology
2015
5
37
Increased haematopoietic progenitor cells are associated with poor outcome in patients with metastatic renal cancer treated with sunitinib
Annals of Oncology
2011
2
38
The role of CA 125 in epithelial ovarian carcinoma
Journal of B U on
2002
1
39
Renal cell cancer: causes, prognosis, management and treatments
Cancer Nursing Practice
2006
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.